Table 2.
Variable | Study eye—n (%) |
---|---|
Lesion type | |
Total | 208 (100%) |
Classic | 83 (39.9%) |
Minimally classic | 23 (11.1%) |
Occult | 71 (34.1%) |
Other shapes | 12 (5.8%) |
RAP | 9 (4.3%) |
IPCV | 3 (1.4%) |
Unknown | 19 (9.1%) |
Lesion size | |
Total | 208 (100%) |
<1 disk | 38 (18.3%) |
1-2 disks | 90 (43.3%) |
>2 disks | 42 (20.2%) |
Unknown | 38 (18.3%) |
Subretinal neovascular membrane location | |
Total | 208 (100%) |
Yuxtapapillar | 3 (1.4%) |
Extrafoveal | 22 (10.6%) |
Yuxtafoveal | 78 (37.5%) |
Subfoveal | 104 (50.0%) |
Subfoveal + Yuxtapapillar | 1 (0.5%) |
Presence of symptoms at diagnosis | |
Total | 208 (100%) |
Yes | 208 (100%) |
Symptoms at diagnosis | |
Sudden and progressive loss of VA | 136 (65.4%) |
Central scotoma | 88 (42.3%) |
Difficulty to read | 49 (23.6%) |
Metamorphopsia | 99 (47.6%) |
Photopsia | 1 (0.5%) |
Other symptoms | 2 (1.0%) |
Other symptoms | |
Total | 2 (100%) |
RAP: retinal angiomatous proliferation; IPCV: idiopathic polypoidal choroidal vasculopathy; VA: visual acuity.